Method for inhibiting lymphokine production
AssigneeFujisawa Pharmaceutical Co., Ltd.
InventorsMasakuni Okuhara, Hirokazu Tanaka, Toshio Goto, Tohru Kino, Hiroshi Hatanaka
Life of this patent
Estimating the term…
Abstract
This invention relates to tricyclo compounds useful for treatment and prevention of resistance by transplantation, graft-versus-host diseases by medulla ossium transplantation autoimmune diseases, infectious diseases, and the like, which can be represented by the following formula: to a process for their production, to a pharmaceutical composition containing the same and to a use thereof.
Claims3
A method for inhibiting lymphokines production comprising administering to a subject in need thereof an amount of a compound of formula (I) effective to inhibit the production of lymphokines:
- wherein
- R1 is hydroxy or pharmaceutically acceptable protected hydroxy selected from the group consisting of 1-(lower alkylthio)(lower)alkyloxy, tri(lower)alkylsilyloxy, lower alkyl-diphenyl-silyloxy, pharmaceutically acceptable organic sulfonic acyloxy, and pharmaceutically acceptable organic carbamic acyloxy,
- R2 is hydrogen or the same meanings as R1,
- R3 is methyl, ethyl, propyl or allyl, n is an integer of 1 or 2, and
- the symbol of a line and dotted line is a single bond or a double bond, or pharmaceutically acceptable basic salts thereof.
Dependencies are inferred from the claim text.